Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patientsMario Bazzan, Dario Roccatello, Claudio Norbiato et al.|Internal and Emergency Medicine|2020Cited by 93
Antiphospholipid Antibodies and Infection: Non Nova Sed NoveSavino Sciascia, Dario Roccatello, Barbara Montaruli et al.|Frontiers in Immunology|2021Cited by 29
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et alMassimo Radin, Simone Baldovino, Savino Sciascia et al.|Arthritis & Rheumatology|2020Cited by 25
Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective studyMario Bazzan, Paolo Prandoni, Barbara Montaruli et al.|Internal and Emergency Medicine|2009Cited by 25
Genetic and molecular evidence for complement dysregulation in patients with HELLP syndromeMario Bazzan, Massimo Cugno, Tullia Todros et al.|Thrombosis Research|2020Cited by 17